Literature DB >> 2985957

myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts.

S Alema, F Tato, D Boettiger.   

Abstract

The effects of the avian viral oncogenes src and myc were compared for their ability to alter the differentiated phenotype and the proliferative capacity of definitive chondroblasts. As previously demonstrated, viruses carrying the src oncogene suppressed the synthesis of the chondroblast-specific products, type II collagen and cartilage-specific sulfated proteoglycan. In contrast, infection with MC29 and HB1 viruses, which carry the myc oncogene, did not suppress the synthesis of these normal differentiated cell products, but the infected cells exhibited an increased proliferative potential. The MH2 virus, which carries both the myc and mil oncogenes, both induced the suppression of these chondroblast-specific products and increased cell proliferation. The implications of these results for cooperation between oncogenes and the multi-oncogene models for neoplastic transformation are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985957      PMCID: PMC366746          DOI: 10.1128/mcb.5.3.538-544.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  25 in total

1.  Transformation of chondroblasts by Rous sarcoma virus and synthesis of the sulfated proteoglycan matrix.

Authors:  M Pacifici; D Boettiger; K Roby; H Holtzer
Journal:  Cell       Date:  1977-08       Impact factor: 41.582

2.  Temperature-sensitive avian sarcoma viruses: a physiological comparison of twenty mutants.

Authors:  J A Wyke; M Linial
Journal:  Virology       Date:  1973-05       Impact factor: 3.616

3.  Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus.

Authors:  P Donner; I Greiser-Wilke; K Moelling
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

4.  Differential effects of transforming avian RNA tumor viruses on avian macrophages.

Authors:  E M Durban; D Boettiger
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

5.  Progenitor-cell populations can be infected by RNA tumor viruses, but transformation is dependent on the expression of specific differentiated functions.

Authors:  D Boettiger; E M Durban
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

6.  Mutants of avian myelocytomatosis virus with smaller gag gene-related proteins have an altered transforming ability.

Authors:  G Ramsay; T Graf; M J Hayman
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

7.  Two retroviruses with similar transforming genes exhibit differences in transforming potential.

Authors:  M Linial
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

8.  Changes in the type II and type I collagen messenger RNA population during growth of chondrocytes in 5-bromo-2-deoxyuridine.

Authors:  P J Pawlowski; G T Brierley; L N Lukens
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

9.  The loss of phenotypic traits by differentiated cells. VI. Behavior of the progeny of a single chondrocyte.

Authors:  S Chacko; J Abbott; S Holtzer; H Holtzer
Journal:  J Exp Med       Date:  1969-08-01       Impact factor: 14.307

10.  Synthesis and extracellular deposition of fibronectin in chondrocyte cultures. Response to the removal of extracellular cartilage matrix.

Authors:  W Dessau; J Sasse; R Timpl; F Jilek; K von der Mark
Journal:  J Cell Biol       Date:  1978-11       Impact factor: 10.539

View more
  19 in total

1.  Transcription of muscle-specific genes is repressed by reactivation of pp60v-src in postmitotic quail myotubes.

Authors:  G Falcone; S Alemà; F Tatò
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

2.  myc products induce the expression of catecholaminergic traits in quail neural crest-derived cells.

Authors:  M Fauquet; D Stehelin; S Saule
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Expression of simian virus 40 large T (tumor) oncogene in mouse chondrocytes induces cell proliferation without loss of the differentiated phenotype.

Authors:  F Mallein-Gerin; B R Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

4.  Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.

Authors:  A MacAuley; T Pawson
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Independent regulation of transcription of the two strands of the c-myc gene.

Authors:  M S Kindy; J E McCormack; A J Buckler; R A Levine; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Characterization of a myc-containing retrovirus generated by propagation of an MH2 viral subgenomic RNA.

Authors:  P Martin; C Henry; F Ferre; C Bechade; A Begue; C Calothy; B Debuire; D Stehelin; S Saule
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

7.  Transcriptional downregulation of the retina-specific QR1 gene by pp60v-src and identification of a novel v-src-responsive unit.

Authors:  A Pierani; C Pouponnot; G Calothy
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Developmental control of transcription of a retina-specific gene, QR1, during differentiation: involvement of factors from the POU family.

Authors:  A Pierani; C Pouponnot; G Calothy
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

9.  Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene.

Authors:  L G Larsson; I Ivhed; M Gidlund; U Pettersson; B Vennström; K Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  Retention or loss of v-mil sequences after propagation of MH2 virus in vivo or in vitro.

Authors:  B Biegalke; M Linial
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.